PICI Collaborates with ASCO to Support Future Leaders in Cancer Immunotherapy

Parker Institute for Cancer Immunotherapy shared a post on LinkedIn:

“We’re excited to announce a new collaboration with American Society of Clinical Oncology (ASCO) to co-fund a Conquer Cancer, the ASCO Foundation, Endowed Young Investigator Award (YIA) to support the next generation of cancer immunotherapy leaders.

Through PICI’s commitment, the Endowed Young Investigator Award (YIA) will provide a $50,000 annual grant to fund early-career oncologists advancing high-quality immunotherapy research and clinical discovery.

PICI CEO Karen Knudsen MBA PhD sat down with Clifford Hudis, CEO of ASCO and executive vice chair of Conquer Cancer, to discuss why sustained investment in emerging investigators is critical to accelerating breakthrough therapies.

Together, we’re helping build the next wave of transformative cancer treatments.

Read more on the news.”

Proceed to the video attached to the post.

More posts about Parker Institute for Cancer Immunotherapy